Axsome Therapeutics AXSM
NASDAQ AXSM
$156.31 -3.27 (-2.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) Short term Debt (2016 - 2026)

Updated

Axsome Therapeutics (AXSM) reported Short term Debt of $70 million for Q2 2026, unchanged from $70 million a year earlier and unchanged from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Short term Debt (2016 - 2026) Analysis & Trends

Dating back to Q4 2016, Axsome Therapeutics' Short term Debt record includes 20 quarters.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $70 million (Q1 2026), $70 million (Q4 2025) and $70 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Axsome Therapeutics 8.09 Bn 6.82 Bn 204.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.00 Mn
Mar 31, 2026 70.00 Mn
Dec 31, 2025 70.00 Mn
Sep 30, 2025 70.00 Mn
Jun 30, 2025 70.00 Mn
Jun 30, 2020 6.55 Mn
Mar 31, 2020 4.57 Mn
Dec 31, 2019 2.60 Mn
Sep 30, 2019 648,523.00
Jun 30, 2019 2.16 Mn
Mar 31, 2019 535,767.00
Dec 31, 2018 3.29 Mn
Sep 30, 2018 3.29 Mn
Jun 30, 2018 3.28 Mn
Mar 31, 2018 3.28 Mn
Dec 31, 2017 3.27 Mn
Sep 30, 2017 2.72 Mn
Jun 30, 2017 1.90 Mn
Mar 31, 2017 1.08 Mn
Dec 31, 2016 269,162.00
API Access

Axsome Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=AXSM&period=max&api_key=YOUR_API_KEY